Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, İzmir, Turkiye.
Department of Medical Microbiology, Faculty of Medicine, Ege University, İzmir, Turkiye.
Turk J Med Sci. 2024 Mar 11;54(4):761-765. doi: 10.55730/1300-0144.5846. eCollection 2024.
BACKGROUND/AIM: Although seasonal human coronaviruses (HCoVs) have long been recognized as respiratory tract viruses, the newly identified SARS-CoV-2 caused a pandemic associated with severe respiratory failure. We aimed to evaluate the incidence of COVID-19 infection in patients diagnosed in three tertiary teaching hospitals, both with and without prior confirmed HCoV infection, and to compare these cohorts in terms of COVID-19 contraction.
In our study, we examined HCoV PCR-positive cases obtained retrospectively between January 2014 and March 2020 from three University Hospital Microbiology Laboratories (Cohort 1), as well as PCR-negative patients detected in the same PCR cycle as the positive cases (Cohort 2). We also evaluated subgroups of HCoV-positive cases.
There was no difference in COVID-19 contraction rates between Cohort 1 and Cohort 2 (p = 0.724). When previous HCoV subgroups of COVID-19-positive patients were examined, no significant difference was found between the betacoronavirus and alphacoronavirus subgroups (p = 0.822), among the four groups (NL63, 229E, OC43, HKU-1) (p = 0.207), or between the OC43 subgroup and the other groups (p = 0.295).
Being previously infected with HCoV did not provide protection against COVID-19 in our study group. We suggest evaluating the possible effect of previous OC43 infection on COVID-19 contraction in larger cohorts.
背景/目的:虽然季节性人类冠状病毒(HCoV)早已被认为是呼吸道病毒,但新发现的 SARS-CoV-2 引起了与严重呼吸衰竭相关的大流行。我们旨在评估在三家三级教学医院诊断的患者中 COVID-19 感染的发生率,这些患者既有先前确诊的 HCoV 感染,也有未感染的患者,并比较这些队列在 COVID-19 感染方面的差异。
在我们的研究中,我们回顾性地检查了三家大学医院微生物实验室在 2014 年 1 月至 2020 年 3 月之间获得的 HCoV PCR 阳性病例(队列 1),以及在与阳性病例相同的 PCR 周期中检测到的 PCR 阴性患者(队列 2)。我们还评估了 HCoV 阳性病例的亚组。
队列 1 和队列 2 之间 COVID-19 感染率无差异(p=0.724)。当检查 COVID-19 阳性患者的先前 HCoV 亚组时,贝塔冠状病毒和阿尔法冠状病毒亚组之间没有发现显著差异(p=0.822),在四个组(NL63、229E、OC43、HKU-1)之间(p=0.207),或在 OC43 亚组与其他组之间(p=0.295)。
在我们的研究组中,先前感染 HCoV 并不能提供对 COVID-19 的保护。我们建议在更大的队列中评估先前 OC43 感染对 COVID-19 感染的可能影响。